Cargando…
Ocular surface complications following biological therapy for cancer
Novel and highly effective biological agents developed to treat cancer over the past two decades have also been linked to multiple adverse outcomes, including unanticipated consequences for the cornea. This review provides an overview of adverse corneal complications of biological agents currently i...
Autores principales: | Ma, Kevin Sheng-Kai, Tsai, Ping-Feng, Hsieh, Tina Yi-Jin, Chodosh, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324604/ https://www.ncbi.nlm.nih.gov/pubmed/37424746 http://dx.doi.org/10.3389/ftox.2023.1137637 |
Ejemplares similares
-
Visual function and quality of life in patients with Stevens-Johnson syndrome who received acute protocol-based ocular care
por: Shanbhag, Swapna S., et al.
Publicado: (2022) -
Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy
por: Ruiz-Lozano, Raul E., et al.
Publicado: (2023) -
Noxious effects of riot control agents on the ocular surface: Pathogenic mechanisms and management
por: Quiroga-Garza, Manuel E., et al.
Publicado: (2023) -
Chemical toxic exposures and chronic ocular pain
por: Graca, Mateusz, et al.
Publicado: (2023) -
More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular Disease
por: Hammond, Christine L., et al.
Publicado: (2022)